Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Patient demographics and baseline clinical characteristics

From: High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

  Number (%)
Pre-selection N = 30 Post-selection N = 115 Overall N = 145
Age (median) 19–68 (52) 28–77 (54) 19–77 (54)
Male 23 (76.7) 82 (71.3) 105 (72.4)
Nephrectomy 26 (86.7) 115 (100) 141 (97.2)
MSKCC risk
 Good 19 (63.3) 98 (85.2) 117 (80.7)
 Intermediate 11 (36.7) 17 (14.8) 28 (19.3)
 Poor 0 0 0
Heng risk
 Favourable 7 (23.3) 60 (52.2) 67 (46.2)
 Intermediate 19 (63.3) 47 (40.9) 66 (45.5)
 Poor 4 (13.3) 8 (6.9) 12 (8.3)
Pathology type
 Favourable 17 (56.7) 106 (92.2) 123 (84.8)
 Other 13 (43.3) 9 (7.8) 22 (15.2)
No of met organ(s)
 1 10 (33.3) 42 (36.5) 52 (35.9)
 2 7 (23.3) 41 (35.7) 48 (33.1)
 3 + 13 (43.3) 32 (27.8) 45 (31.0)